Osteochondrosis (OC) is an injury to cartilage canals with a following necrosis in the growth cartilage, from there it can develop to osteochondrosis dissecans (OCD). Due to its high impact in the equine industry, new insights into predisposing factors and potential high-risk genetic variants are warranted. This article reviews advancements in quantitative and molecular genetics in refining estimation of genetic parameters and identifying predisposing genetic loci. Heritabilities were highest for hock OC with estimates at 0.29-0.46 in Hanoverian warmblood and Norwegian trotters, whereas in Thoroughbreds only very low genetic variation seemed to be present in hock OC lesions. Whole genome scans using the Illumina Equine SNP50 or SNP70 Beadchip were performed in Thoroughbred, Standardbred, French and Norwegian trotter, Hanoverian and Dutch warmblood. Validation studies in Spanish Purebred and Hanoverian warmblood horses corroborated OC risk loci on ECA 3, 14, 27 and 29. Particularly, a strong association with hock-OCD was found for a single nucleotide polymorphism (SNP) on horse chromosome (ECA) 3 upstream to the LCORL gene. Gene expression and microRNA analyses may be helpful to understand pathophysiological processes in equine OC and to connect OCD-associated genomic regions with potential candidate genes. Furthermore progress in elucidating the underlying genetic variants and pathophysiological changes in OC may be expected from whole genome DNA and RNA next-generation sequencing studies.
Introduction
Osteochondrosis (OC) is a common lesion in young horses affecting the growing cartilage of the articular/epiphyseal complex of predisposed joints at specific predilection sites. Abnormal cartilage can be thickened, collapsed or progress to cartilage flaps or osteochondral fragments separated from the subchondral bone leading to osteochondrosis dissecans (OCD). Ischaemia of the growth cartilage and alteration of the type II collagen synthesis were proposed as important factors in pathogenesis [1] . Clinical signs of OC/OCD become evident in young horses with increasing training and without surgical intervention may lead to a decrease in the performance and durability of horses [2] . Most commonly affected articulations include the metacarpophalangeal/ metatarsophalangeal (MCP/MTP, fetlock), tarsocrural (TC, hock) and femoropatellar (FP, stifle) joints [3] . Predilection sites are the dorsoproximal aspect of the sagittal ridge of the third metacarpal/metatarsal bone, in hock joints the sagittal ridge of the distal tibia, the lateral and medial malleolus of the tibia, the lateral and medial trochlea and the basis of the talus and in stifle joints the lateral and medial trochlea of the femur, the sulcus intertrochlearis and the patella. Radiographic signs consistent with OC include an irregular texture of the bone with variable radiopacity and changes of the regular bone contour including irregularly flattened contours, smaller or larger concavities, or isolated radiodense areas at the specific predilection sites of the joints. Progression of these primary lesions may lead to further damage of the joint with cartilage flaps and osteochondral fragments. The development of OC/OCD seems to be multifactorial including genetic predisposition, exercise [4, 5] , endocrinological and nutritional factors [6, 7] and growth rate in foals [8] .
OC/OCD has been the topic of numerous reports and articles in Equine Veterinary Journal over the past 50 years. The objective of the current article is to review the current status of the quantitative and molecular genetics in identifying OC-risk loci using single nucleotide polymorphisms (SNPs) and single nucleotide variants (SNVs) because OC/OCD shows moderate to high heritabilities and has a high animal welfare impact due its frequent prevalence and health issues later in life. In addition, the results of a validation study for hock-OCD are summarised and the outcomes of genome-wide association studies (GWAS) are compared with gene expression studies.
Quantitative genetics for equine osteochondrosis
Previously published studies across different breeds reported prevalences of OC and OCD in different limb joints between 3.1 and 69% [9] . Prevalence and heritability estimates vary among breeds, the investigated joints and the predilection sites [2] . Radiographic surveys showed fetlock-OC prevalences from 7.2 to 14.9% in warmblood breeds and Thoroughbreds [10] [11] [12] [13] , while French trotters (32%) [14] and South German coldbloods (53.9%) [15] showed higher prevalences. Hock-OC prevalences varied from 5 to 9.7% in warmblood horses and Thoroughbreds [10] [11] [12] [13] , from 17 to 23% in Standardbreds [14, 16] and were 40.1% in South German Coldbloods [15] . Stifle-OCD in Thoroughbreds and warmblood breeds reached prevalences of 4.3-10% [10] [11] [12] [13] . A previous review summarised the heritability estimates from 15 different studies [2] . In a recent study in Hanoverian warmblood estimated heritabilities were 0.16-0.17 for fetlock OC/OCD, 0.35-0.46 for hock OC/OCD and 0.21-0.23 for stifle OC/OCD [13] (Table 1) . Similar heritability estimates were found for OC at the distal intermediate ridge of the tibia and the lateral trochlear ridge of the talus in Norwegian Standardbred trotters [16] . Contrasting results were obtained for Australian Thoroughbred with low heritabilities at 0.08 for any OC, 0.02 for any fetlock OC, 0.0 for any tarsal OC and 0.16 for any stifle OC [10] . Standardbreds are particularly predisposed to OC/OCD in the hock joints [16] and South German Coldblood to OC/OCD in hock and fetlock joints in comparison to 
Linked and associated risk loci for osteochondrosis
With the completion of the horse whole genome sequencing project, an equine reference genome assembly EquCab2.0 was released [17] and a large number of highly polymorphic microsatellites and single nucleotide polymorphisms (SNPs) became available [17, 18] . For genome-wide association studies (GWAS) in horses, the equine SNP50 and SNP70 Genotyping Beadchip with 50 and 70 K SNPs as well as an Affymetrix chip with 660 K SNPs were developed covering the genome with a moderatehigh SNP-density (EquCab2.0-based). Whole genome scans using microsatellites were performed for Hanoverian warmblood and South German coldblood using half sib families [19, 20] . These studies revealed genome-wide significant quantitative trait loci (QTL) on horse chromosome (ECA) 2, 4, 5, and 16 in Hanoverian warmblood [19] and on ECA 5, 15, 16, 17, 23, 27 28 and 31 for South German coldblood [20] . Fine mapping in Hanoverian warmblood confirmed QTLs on ECA 2, 4, 5, 16, 18 and 21 [21] [22] [23] [24] [25] [26] .
Genome-wide association studies (GWAS) have progressed into a powerful approach for identifying SNPs associated with complex diseases. GWAS for OC/OCD using the Equine SNP50 and/or the SNP70 Beadchip a were performed in Hanoverian warmblood horses [27] , Norwegian Standardbreds [28] , French trotters [14] , Dutch Warmblood horses [29] and US Standardbreds [30] (Supplementary Item 1). These studies identified putatively OC/OCD-associated SNPs and SNVs on ECA 1, 2, 3, 4, 6, 10, 14, 16, 18, 26, 27, 28, 29 and 30. There was limited evidence for consistent loci across the different horse breeds. A validation study with 144 Spanish Purebred horses using 48 intragenic genetic variants from previous reports showed suggestive associations for two SNPs on ECA 2 and 4 and a significant association for one SNP on ECA 2 [31] .
Validation of OCD-associated genetic variants
A sample of Hanoverian warmblood horses (n = 440) was collected in the years 2005-2012. Sampling took into account ancestry, sex and origin of horses in order to avoid stratification by these factors. Only those genetic variants which have been declared as most significantly associated with hock-OCD in the respective previously reported GWAS were selected for this validation study (Supplementary Item 1). Data included 440 young Hanoverian warmblood horses with a standardised radiological examination following the approved rules of prepurchase horse veterinary medical examinations laid down in the 'R€ ontgenleitfaden' [32] . The veterinary examination comprised at least twelve x-rays of all four limbs, latero-lateral projections of the front and hind toes, dorsoproximalpalmarodistal projections of the region of the navicular bone of both forelimbs according to Oxspring [33] , 45°and 115°projections of the hocks and 90°projections of the stifles. Two experienced radiologists examined the radiographs independently. If there was no agreement about the radiological findings, radiographs were re-examined in order to obtain a unanimous veterinary report. A more detailed description of the data can be found elsewhere [13] . Controls (n = 214) had to be healthy, free from OC and OCD and any other limb diseases. All affected horses (n = 226) had a diagnosis of OCD. Diagnosis of OC/OCD included the commonly agreed predilection sites in MCP/MTP, hock and stifle joints. Among the affected horses, 99 animals had OCD in the fetlock, 133 in the hock and 13 in the stifle joint (Supplementary Item 2). Mean age of the horses was between 3 and 5 years. We performed a case-control analysis for OCD across all joints and OCD in fetlock, hock or stifle joints and calculated odds ratios (ORs) for allele frequencies among controls and OCD-affected horses employing the CASE-CONTROL procedure of SAS/Genetics, version 9. -tests for Hardy-Weinberg equilibria (HWE) were determined using the ALLELE procedure of SAS/ Genetics (Supplementary Items 4-8) . Multiple testing was accounted for using a Bonferroni correction with the MULTIPLE TEST procedure of SAS. For a further search of associated SNPs adjacent to genetic variants genotyped, we employed imputation for ECA 3, 4, 10, 14 and 27 based on the genotypic data of the Equine Illumina SNP50 Beadchip. Imputation was performed using BEAGLE 3.3.2 [34, 35] . In addition, we performed a mixed linear model (MLM) analysis to account for possible stratification effects due to non-random sampling. The respective genotype and sex of the horse were regarded as fixed effects and a random animal effect was parameterised through an identity-by-state-kinship (IBS) matrix. The IBSmatrix was calculated using the imputed SNPs. We used PLINK d , version 1.9 [36] , for construction of the IBS-matrix and TASSEL e , version 5.0, for performing MLM analyses [37] . Case-control analysis showed ten genetic variants on four different chromosomes (ECA 3, 14, 27 and 29) as nominally significant (P<0.05) for fetlock-, stifle-, hock-OCD or OCD in total (Table 2) . After correcting for multiple testing two genetic variants remained significant (P<0.05). The strongest association for hock-OCD and OCD in total was seen for the SNP BIEC2-808543 (rs68603064) on ECA 3. MLM-analyses gave for the SNP BIEC2-808543 (rs68603064) results consistent with the case-control analysis. For hock-, fetlock-OCD and OCD in total, a further genetic variant (rs68945244) within MCTP1 on ECA 14 reached significance in the casecontrol analysis after multiple testing. Of the other eight nominally significant genetic variants in the case-control analysis, five are located intragenic and one intergenic on ECA 14, one intergenic on ECA 27 and one intergenic on ECA 29. The strongest OCD-associated SNP BIEC2-808543 on ECA 3 is located 63 kb upstream to the gene LCORL (liganddependent nuclear receptor corepressor-like gene). This SNP had been shown to be associated with relative expression levels of the gene LCORL and body size in Hanoverian warmblood and other horse breeds [38] [39] [40] and laryngeal neuropathy [41] . The present study confirmed the significant associations for the region proximal to LCORL as previously shown for Dutch warmblood (BIEC2-808543 at P = 5.03 9 10 À07 [29] and French trotters (BIEC2-808617 and BIEC2-808442 at P = 11.5-3.0 9 10 À6 , [14] . In summary, our results for loci significantly associated with hock-OCD completely agree with the GWAS in French trotters as both studies identified the same locus on ECA 3 and the same SNP on ECA 14 as significant.
Body size of horses was found to be associated with OC/OCD [42] [43] [44] . A predisposition for OC/OCD in young fast-growing [7, 42, 43, 45] or heavy horses [46, 47] and moderately positive additive genetic correlations between height at withers [44] and osseous fragments in equine limb joints are supportive for the association found here for the SNP BIEC2-808543. For ECA 14, 6/10 genetic variants genotyped in this study were significant in US Standardbreds [30] and 1/10 in French trotters [14] . The rs69296931 SNP on ECA 27 was significantly associated with OCD in Norwegian trotters [28] . For the SNP on ECA 29, a significant association was previously reported in Hanoverian warmblood horses [27] .
Screening of the regions adjacent to the significantly OCD-associated genetic variants on ECA 3 and 14 gave further support for these genomic regions as associated SNPs were identified after imputation of the Equine Illumina SNP50 Beadchip data (Supplementary Item 10) .
We have validated the SNP BIEC2-808543 as strongly associated in Hanoverian warmblood horses indicating that increasing body size may confer a genetic disposition for OCD. In addition, genetic variants within or next to the genes MAT2B, CCNG1, GABRA6, ARHGAP26, SPRY4, MCTP1 and DLGAP2 may play a role in the etiopathogenesis of OCD. MAT2B on ECA 14 belongs to the methionine adenosyltransferase family and catalyses the biosynthesis of S-adenosylmethionine which plays a role in the osteoclastogenesis [48] . CCNG1 on ECA 14 is part of the cyclin family, which is involved in the chondrocyte differentiation and proliferation [49] . Cyclin D1-deficient mice developed dwarfism and chondrocytes had a reduced zone of proliferation [50] . The ARGHAP26 gene on ECA 14 is a Rho GTPase activating protein, which has an important function in the postnatal cartilage development, chondrocyte differentiation and long bone development [51, 52] . SPRY4 (sprouty homolog 4) encodes a protein, antagonising the fibroblast growth factors pathway. This pathway is involved in chondrocyte differentiation [53] . For the genes GABRA6 (gamma-aminobutyric acid type A receptor) and MCTP1 (multiple C2 and transmembrane domain) on ECA 14 and DLGAP2 (DLG associated protein 2) on ECA 27 no functional relationships with cartilage or bone tissue metabolisms has been reported.
Gene-expression studies
The gene-expression studies focused on chondrocyte function to retrieve molecular pathways important for developing OC (Supplementary Item 11) . These studies may help to understand the pathophysiology OC/OCD and may serve to guide forthcoming studies. In these studies, particularly genes playing a role in encoding of extracellular matrix proteins, secretory pathways proteins or cell signalling pathways and growth plate maturation were selected for comparing expression levels among OC-affected horses and OC-non affected horses or among affected and non-affected joints within the same horses [54] .
An altered gene expression was found in early-induced OC lesions of horses fed with a high energy diet for several weeks. Comparing OCaffected cartilage with normal cartilage from the same joint, an increase in MMP13 (matrix metallopeptidase 13) and Runx2 (runt related transcription factor 2) expression in lesion cartilage was detected [55] . As hypertrophic chondrocytes normally express these genes [56] it is suggested that OC is TABLE 2: Results of the case-control and mixed linear model (MLM) analysis of the ten genetic variants or single nucleotide polymorphisms (SNPs) reaching a nominally significant P-value<0.05 for osteochondrosis dissecans (OCD) in Hanoverian warmblood horses. Given are the horse chromosome (ECA), the position in base pairs (bp), the SNP-ID, the minor allele (MA), the minor allele frequency (MAF), odds ratios (ORs) with their 95% confidence intervals (CI), Àlog 10 P-values for genotype and allele and the nearest gene with its distance in kb for the traits OCD in total (T), hock-OCD (H), fetlock-OCD (F) and stifle-OCD (S) not the result from failure of chondrocytes. In a further study using substractive hybridisation, which allowed the detection of unknown OCassociated genes, the expression-levels of these genes differed again and eight new significantly differently expressed genes were discovered. The majority of the significantly differently expressed genes encode extracellular proteins or proteins with an extracellular matrix turnover function (integrin aV, lumican, osteopontin, IBS, ATP6V0D2, cathepsin K) while thymosin b4 had a role in the cell signalling pathways and LRP4 (lowdensity lipoprotein receptor-related protein) interacts with the Wntpathway. These results lead to the hypothesis that OC is due to a fundamental defect that induces a cartilage retention in subchondral bone [57] . Austbø et al. [58] found an altered expression of TLK2 (tousled-like kinase 2) and an unknown gene (CD465746.1) in cartilage samples of hock joints of Standardbred foals, obtained by breeding parents with OC-hock, and compared with OC-non-affected foals. Tousled-like kinases (TLKs) encoding nuclear serine/threonine kinases play a role in the regulation of chromatin assembly and are indirectly effecting transcription of genes. Due to their linkage to ongoing DNA replication, it is speculated that an early upregulation of TLK2 could have an effect on the number of dividing cells due to recovery of damaged tissue or growth rate caused by OC in the predisposed horses [58] . Serteyn et al. [59] analysed the gene-expression of leucocytes comparing OC-affected young Belgian Warmblood horses to OC-non-affected horses and discovered significantly different expression levels in genes from pathways influencing cartilage differentiation and endochondral ossification during bone development. These genes were involved in Ihh (Indian hedgehog), PDGF-A (platelet derived growth factor-A), PTH-rP and indirectly Wnt/b-catenin signalling pathways (via the protein sclerostin) demonstrating that metabolic components and other noncartilage-related mechanisms such as insulin resistance may play a role in the OC pathogenesis. A study on femoropatellar joints of OC-affected foals and OC-non-affected foals confirmed these results [60] as well as an MMP-13 increased relative expression in OC lesions [55] . An increasing Wnt inhibitor expression (Wif-1, Axin1, Dkk-1) in femoropatellar joint cartilage of OC-affected foals in comparison to OC-non-affected foals [61] may influence the retonic acid signalling pathway and may have an inhibitory effect on chondrocyte maturation [62] . The role of PTH-rP, Wnt/b-catenin signalling and Ihh pathways was shown in several studies [59, 61, 63] and genes on these pathways partially correspond with OC-risk loci [54] (Supplementary Item 11).
Micro-RNA
Next-generation-sequencing (NGS) of horse DNA or RNA offers great possibilities for detecting new genetic variants involved in diseases. In a recent study using NGS-technology (SOLiD   TM   ) f , short sequences of RNA (18-24 nucleotides) also called microRNAs have emerged as potential new biomarkers for OC/OCD [64] . The role and biological function of small noncoding microRNAs in equine medicine and specifically in cartilage has already been summarised [65, 66] .
In 37 Anglo-Arabian foals micro-RNA sequencing of the cartilage and subchondral bone revealed the expression profile of micro-RNA in these tissues [64] (Supplementary Item 11) . Out of 609 and 622 identified miRNAs in cartilage and subchondral bone, 49 and 41 have been shown to be differentially expressed, respectively. Three of the differentially expressed miRNAs overlap with previously published OC/OCD-QTL. New-eca-mir-696 and new-eca-mir-754 were differentially expressed in cartilage and overlap with OC/OCD-QTL on ECA 17 and 20 [14] . Eca-mir-1249, modulated in bone, overlaps with an OC/OCD-QTL on ECA 28 [28] . In cartilage, miRNAs play a role in the regulation of cartilage and energy metabolism and extracellular matrix synthesis. In bone, miRNA targets were associated with bone development and remodelling including growth factor signalling pathways, regulation of energy production and acidic vesicle transport. Nevertheless, it remains unclear how the differently expressed microRNAs induce OC lesions [64] . A second recent study performed a miRNA screening of the synovial fluid of ten French trotters [67] . The resulting expression profile of miRNAs using qPCR revealed further 10 putatively OC-implicated pathways including endocytosis, actin cytoskeleton, PI3K-Akt signalling, TGF-b signalling, focal adhesion, ubiquitin proteolysis, calcium signalling, MAPK signalling and insulin signalling.
Differentially expressed cartilage miRNAs genes suggest that changes in cell differentiation, energy production, metabolism, extracellular matrix and cartilage homeostasis are associated with OC. In bone, differences among miRNA expressions were associated with the regulation of energy production, vesicle transport and some growth factor signalling pathways.
Conclusions
Osteochondrosis is a complex genetic disease with high impact on animal welfare and performance. Genetic effects significantly contribute to the development of OC. QTL on ECA 2, 3, 4, 14, 27 and 29 seem to correspond among different horse breeds. Linking previous association studies into an across-breed-study could help to identify OC-associated loci in multiple breeds. A locus on ECA 3 in linkage disequilibrium with the size-related gene LCORL seems to be of great importance for OCD in warmblood horse breeds. Next-generation-sequencing of whole genome DNA and RNA opens the way to the most powerful analyses for unravelling of genetic and structural variants involved in the development of OC. Substantial progress in both, genomic and expression analyses may be expected in the near future through the ongoing improvements in the sequence technology.
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